A study of 830,393 adults found no lower dementia rate among users of newer beta-3 agonists for overactive bladder compared with older anticholinergic drugs, though the observational design limits conclusions.
Newer Overactive Bladder Drugs Showed No Dementia Advantage Over Older Pills in Records Study of 830,000 Adults
by | Nov 18, 2026 | Uncategorized | 0 comments

Recent Comments